UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 14, 2020
Accession Number:
0001193125-20-268644
Submission Type:
POS AM
CIK:
0001631650
Company Name:
Aimmune Therapeutics, Inc.
File Number:
333-213499